OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
Jing Miao, Sandra M. Herrmann
Clinical Kidney Journal (2023) Vol. 16, Iss. 11, pp. 1834-1844
Open Access | Times Cited: 14
Jing Miao, Sandra M. Herrmann
Clinical Kidney Journal (2023) Vol. 16, Iss. 11, pp. 1834-1844
Open Access | Times Cited: 14
Showing 14 citing articles:
Association of Proton Pump Inhibitor Use and Immune Checkpoint Inhibitor-Mediated Acute Kidney Injury: A Meta-Analysis and a Review of Related Outcomes
Arjunmohan Mohan, Pajaree Krisanapan, Supawit Tangpanithandee, et al.
American Journal of Nephrology (2024) Vol. 55, Iss. 4, pp. 439-449
Closed Access | Times Cited: 4
Arjunmohan Mohan, Pajaree Krisanapan, Supawit Tangpanithandee, et al.
American Journal of Nephrology (2024) Vol. 55, Iss. 4, pp. 439-449
Closed Access | Times Cited: 4
Clinicopathological Characteristics and Kidney Outcomes in Biopsy-Confirmed Acute Interstitial Nephritis
Jing Miao, Charat Thongprayoon, Pajaree Krisanapan, et al.
Kidney International Reports (2024) Vol. 9, Iss. 12, pp. 3542-3552
Open Access | Times Cited: 3
Jing Miao, Charat Thongprayoon, Pajaree Krisanapan, et al.
Kidney International Reports (2024) Vol. 9, Iss. 12, pp. 3542-3552
Open Access | Times Cited: 3
Association between Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Acute Kidney Injury: A Nested Case–Control Study
Chinami Yamawaki, Shunsaku Nakagawa, Keiko Ikuta, et al.
Kidney360 (2024) Vol. 5, Iss. 9, pp. 1262-1269
Open Access | Times Cited: 1
Chinami Yamawaki, Shunsaku Nakagawa, Keiko Ikuta, et al.
Kidney360 (2024) Vol. 5, Iss. 9, pp. 1262-1269
Open Access | Times Cited: 1
Proton pump inhibitors and adverse kidney outcomes during immune checkpoint blockade: time to sound the alarm?
Hui Zhuan Tan, Ben Sprangers
Clinical Kidney Journal (2023) Vol. 16, Iss. 11, pp. 1709-1713
Open Access | Times Cited: 2
Hui Zhuan Tan, Ben Sprangers
Clinical Kidney Journal (2023) Vol. 16, Iss. 11, pp. 1709-1713
Open Access | Times Cited: 2
Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population‐based cohort study
Philip Vestergaard Munch, Mette Nørgaard, Uffe Heide‐Jørgensen, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 7, pp. 1164-1173
Open Access | Times Cited: 2
Philip Vestergaard Munch, Mette Nørgaard, Uffe Heide‐Jørgensen, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 7, pp. 1164-1173
Open Access | Times Cited: 2
Acute Kidney Injury After the Concurrent Use of Checkpoint Inhibitors and Proton Pump Inhibitors
Helen Gandler, Niveditha Badrinarayanan, Anthony E. Calderon, et al.
Annals of Internal Medicine Clinical Cases (2024) Vol. 3, Iss. 2
Open Access
Helen Gandler, Niveditha Badrinarayanan, Anthony E. Calderon, et al.
Annals of Internal Medicine Clinical Cases (2024) Vol. 3, Iss. 2
Open Access
Immune Checkpoint Inhibitors in Recipients of Renal Allografts
Karthik Venkataraman, Tania Salehi, Robert Carroll
Seminars in Nephrology (2024) Vol. 44, Iss. 1, pp. 151500-151500
Closed Access
Karthik Venkataraman, Tania Salehi, Robert Carroll
Seminars in Nephrology (2024) Vol. 44, Iss. 1, pp. 151500-151500
Closed Access
Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience
Omar Elghawy, Reema Patel, Adam Barsouk, et al.
Journal of Oncology Pharmacy Practice (2024)
Closed Access
Omar Elghawy, Reema Patel, Adam Barsouk, et al.
Journal of Oncology Pharmacy Practice (2024)
Closed Access
Immunotherapy efficacy and toxicity: Reviewing the evidence behind patient implementable strategies
Marthe August Marianne Verhaert, Sandrine Aspeslagh
European Journal of Cancer (2024) Vol. 209, pp. 114235-114235
Closed Access
Marthe August Marianne Verhaert, Sandrine Aspeslagh
European Journal of Cancer (2024) Vol. 209, pp. 114235-114235
Closed Access
Management Update in Immunotherapy and Kidney Injury
Clara García-Calvo, Francisco Gonçalves, María José Soler, et al.
Interdisciplinary cancer research (2024)
Closed Access
Clara García-Calvo, Francisco Gonçalves, María José Soler, et al.
Interdisciplinary cancer research (2024)
Closed Access
Clinical studies on adverse effects of gastrointestinal drugs
Dianne May, Devin L. Lavender, Emily Hightower
Side effects of drugs annual (2024), pp. 393-407
Closed Access
Dianne May, Devin L. Lavender, Emily Hightower
Side effects of drugs annual (2024), pp. 393-407
Closed Access
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Nephrotoxicity: A Position Statement from the American Society of Onco-nephrology
Sandra M. Herrmann, Ala Abudayyeh, Shruti Gupta, et al.
Kidney International (2024)
Closed Access
Sandra M. Herrmann, Ala Abudayyeh, Shruti Gupta, et al.
Kidney International (2024)
Closed Access
Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process
Anthony Brade, Houda Bahig, Andrea Bezjak, et al.
Current Oncology (2024) Vol. 31, Iss. 11, pp. 6512-6535
Open Access
Anthony Brade, Houda Bahig, Andrea Bezjak, et al.
Current Oncology (2024) Vol. 31, Iss. 11, pp. 6512-6535
Open Access
Nebenwirkungsmanagement bei Immuncheckpointinhibitoren
Anna Reischer, Kathrin Heinrich, Michael von Bergwelt‐Baildon
InFo Hämatologie + Onkologie (2023) Vol. 26, Iss. 9, pp. 26-31
Closed Access
Anna Reischer, Kathrin Heinrich, Michael von Bergwelt‐Baildon
InFo Hämatologie + Onkologie (2023) Vol. 26, Iss. 9, pp. 26-31
Closed Access
